Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Medium-term Electrophysiologic Effects of a Cellularized Scaffold Implanted in Rats After Myocardial Infarction.

Kolettis TM, Bagli E, Barka E, Kouroupis D, Kontonika M, Vilaeti AD, Markou M, Roumpi M, Maltabe V, La Rocca V, Agathopoulos S, Fotsis T.

Cureus. 2018 Jul 10;10(7):e2959. doi: 10.7759/cureus.2959.

2.

Mechanical stress affects methylation pattern of GNAS isoforms and osteogenic differentiation of hAT-MSCs.

Vlaikou AM, Kouroupis D, Sgourou A, Markopoulos GS, Bagli E, Markou M, Papadopoulou Z, Fotsis T, Nakos G, Lekka ME, Syrrou M.

Biochim Biophys Acta Mol Cell Res. 2017 Aug;1864(8):1371-1381. doi: 10.1016/j.bbamcr.2017.05.005. Epub 2017 May 5.

3.

Generation of human induced pluripotent stem cells in defined, feeder-free conditions.

Kyrkou A, Stellas D, Syrrou M, Klinakis A, Fotsis T, Murphy C.

Stem Cell Res. 2016 Sep;17(2):458-460. doi: 10.1016/j.scr.2016.05.006. Epub 2016 May 12.

4.

VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis.

Basagiannis D, Zografou S, Murphy C, Fotsis T, Morbidelli L, Ziche M, Bleck C, Mercer J, Christoforidis S.

J Cell Sci. 2016 Nov 1;129(21):4091-4104. Epub 2016 Sep 21.

5.

Generation of stem cell-based bioartificial anterior cruciate ligament (ACL) grafts for effective ACL rupture repair.

Kouroupis D, Kyrkou A, Triantafyllidi E, Katsimpoulas M, Chalepakis G, Goussia A, Georgoulis A, Murphy C, Fotsis T.

Stem Cell Res. 2016 Sep;17(2):448-457. doi: 10.1016/j.scr.2016.04.016. Epub 2016 Apr 22.

6.

Intracellular labile iron determines H2O2-induced apoptotic signaling via sustained activation of ASK1/JNK-p38 axis.

Mantzaris MD, Bellou S, Skiada V, Kitsati N, Fotsis T, Galaris D.

Free Radic Biol Med. 2016 Aug;97:454-465. doi: 10.1016/j.freeradbiomed.2016.07.002. Epub 2016 Jul 5.

PMID:
27387771
7.

Proteome Changes during Transition from Human Embryonic to Vascular Progenitor Cells.

Tsolis KC, Bagli E, Kanaki K, Zografou S, Carpentier S, Bei ES, Christoforidis S, Zervakis M, Murphy C, Fotsis T, Economou A.

J Proteome Res. 2016 Jun 3;15(6):1995-2007. doi: 10.1021/acs.jproteome.6b00180. Epub 2016 May 13.

PMID:
27146950
8.

Signal Transduction: Gain of Activin Turns Muscle into Bone.

Sanchez-Duffhues G, Fotsis T, ten Dijke P.

Curr Biol. 2015 Dec 7;25(23):R1136-8. doi: 10.1016/j.cub.2015.10.005.

9.

The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.

Yang J, AlTahan AM, Hu D, Wang Y, Cheng PH, Morton CL, Qu C, Nathwani AC, Shohet JM, Fotsis T, Koster J, Versteeg R, Okada H, Harris AL, Davidoff AM.

J Natl Cancer Inst. 2015 Apr 29;107(6):djv080. doi: 10.1093/jnci/djv080. Print 2015 Jun.

10.

VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis.

Karali E, Bellou S, Stellas D, Klinakis A, Murphy C, Fotsis T.

Mol Cell Oncol. 2014 Dec 23;1(3):e964024. doi: 10.4161/23723548.2014.964024. eCollection 2014 Jul-Sep.

11.

VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress.

Karali E, Bellou S, Stellas D, Klinakis A, Murphy C, Fotsis T.

Mol Cell. 2014 May 22;54(4):559-72. doi: 10.1016/j.molcel.2014.03.022. Epub 2014 Apr 17.

12.

SARA and RNF11 at the crossroads of EGFR signaling and trafficking.

Kostaras E, Pedersen NM, Stenmark H, Fotsis T, Murphy C.

Methods Enzymol. 2014;535:225-47. doi: 10.1016/B978-0-12-397925-4.00014-6.

PMID:
24377927
13.

Anti-angiogenesis in cancer therapy: Hercules and hydra.

Bellou S, Pentheroudakis G, Murphy C, Fotsis T.

Cancer Lett. 2013 Sep 28;338(2):219-28. doi: 10.1016/j.canlet.2013.05.015. Epub 2013 May 21. Review.

PMID:
23707856
14.

The RhoD to centrosomal duplication.

Kyrkou A, Soufi M, Bahtz R, Ferguson C, Bai M, Parton RG, Hoffmann I, Zerial M, Fotsis T, Murphy C.

Small GTPases. 2013 Apr-Jun;4(2):116-22. doi: 10.4161/sgtp.23707. Epub 2013 Feb 19.

15.

SARA and RNF11 interact with each other and ESCRT-0 core proteins and regulate degradative EGFR trafficking.

Kostaras E, Sflomos G, Pedersen NM, Stenmark H, Fotsis T, Murphy C.

Oncogene. 2013 Oct 31;32(44):5220-32. doi: 10.1038/onc.2012.554. Epub 2012 Dec 10.

PMID:
23222715
16.

RhoD participates in the regulation of cell-cycle progression and centrosome duplication.

Kyrkou A, Soufi M, Bahtz R, Ferguson C, Bai M, Parton RG, Hoffmann I, Zerial M, Fotsis T, Murphy C.

Oncogene. 2013 Apr 4;32(14):1831-42. doi: 10.1038/onc.2012.195. Epub 2012 Jun 4.

PMID:
22665057
17.

The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.

Bellou S, Karali E, Bagli E, Al-Maharik N, Morbidelli L, Ziche M, Adlercreutz H, Murphy C, Fotsis T.

Mol Cancer. 2012 May 14;11:35. doi: 10.1186/1476-4598-11-35.

18.

Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.

Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, Golfinopoulos V, Cervantes A, Bobos M, Fotsis T, Bellou S, Fountzilas G, Malamou-Mitsi V, Pavlidis N.

Anticancer Res. 2012 Apr;32(4):1273-81.

PMID:
22493359
19.

ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN.

Sflomos G, Kostaras E, Panopoulou E, Pappas N, Kyrkou A, Politou AS, Fotsis T, Murphy C.

J Cell Sci. 2011 Oct 1;124(Pt 19):3209-22. doi: 10.1242/jcs.062307. Epub 2011 Aug 30.

20.

Gene expression profile associated with oncogenic ras-induced senescence, cell death, and transforming properties in human cells.

Moumtzi SS, Roberts ML, Joyce T, Evangelidou M, Probert L, Frillingos S, Fotsis T, Pintzas A.

Cancer Invest. 2010 Jul;28(6):563-87. doi: 10.3109/07357900903095623.

PMID:
19883200
21.

VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells.

Bellou S, Hink MA, Bagli E, Panopoulou E, Bastiaens PI, Murphy C, Fotsis T.

Am J Physiol Cell Physiol. 2009 Dec;297(6):C1477-89. doi: 10.1152/ajpcell.00058.2009. Epub 2009 Sep 9.

22.

Control of transforming growth factor beta signal transduction by small GTPases.

Kardassis D, Murphy C, Fotsis T, Moustakas A, Stournaras C.

FEBS J. 2009 Jun;276(11):2947-65. doi: 10.1111/j.1742-4658.2009.07031.x. Epub 2009 Apr 23. Review.

23.

Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells.

Goulas V, Exarchou V, Troganis AN, Psomiadou E, Fotsis T, Briasoulis E, Gerothanassis IP.

Mol Nutr Food Res. 2009 May;53(5):600-8. doi: 10.1002/mnfr.200800204.

PMID:
19194970
24.

Matrix metalloproteinases in carcinoma of unknown primary.

Karavasilis V, Malamou-Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, Fountzilas G, Fotsis T, Pavlidis N.

Cancer. 2005 Nov 15;104(10):2282-7.

25.

Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.

Panopoulou E, Murphy C, Rasmussen H, Bagli E, Rofstad EK, Fotsis T.

Cancer Res. 2005 Mar 1;65(5):1877-86.

26.

Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.

Karavasilis V, Malamou-Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, Fountzilas G, Fotsis T, Pavlidis N.

BMC Cancer. 2005 Mar 3;5:25.

27.

An isotope dilution gas chromatographic-mass spectrometric method for the simultaneous assay of estrogens and phytoestrogens in urine.

Adlercreutz H, Kiuru P, Rasku S, Wähälä K, Fotsis T.

J Steroid Biochem Mol Biol. 2004 Dec;92(5):399-411. Epub 2005 Jan 8.

PMID:
15698545
28.
29.

Angiogenesis in inflammation.

Bagli E, Xagorari A, Papetropoulos A, Murphy C, Fotsis T.

Autoimmun Rev. 2004 Jun;3 Suppl 1:S26. Review. No abstract available.

PMID:
15309776
30.

Decrease of heat shock protein levels and cell populations by wine phenolic extracts.

Roussou I, Lambropoulos I, Pagoulatos GN, Fotsis T, Roussis IG.

J Agric Food Chem. 2004 Feb 25;52(4):1017-24.

PMID:
14969565
31.

N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma.

Hatzi E, Murphy C, Zoephel A, Ahorn H, Tontsch U, Bamberger AM, Yamauchi-Takihara K, Schweigerer L, Fotsis T.

Eur J Biochem. 2002 Aug;269(15):3732-41.

32.

N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth.

Hatzi E, Murphy C, Zoephel A, Rasmussen H, Morbidelli L, Ahorn H, Kunisada K, Tontsch U, Klenk M, Yamauchi-Takihara K, Ziche M, Rofstad EK, Schweigerer L, Fotsis T.

Oncogene. 2002 May 16;21(22):3552-61.

33.

Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice.

Kotanidou A, Xagorari A, Bagli E, Kitsanta P, Fotsis T, Papapetropoulos A, Roussos C.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):818-23.

PMID:
11897650
34.

Early endosomal regulation of Smad-dependent signaling in endothelial cells.

Panopoulou E, Gillooly DJ, Wrana JL, Zerial M, Stenmark H, Murphy C, Fotsis T.

J Biol Chem. 2002 May 17;277(20):18046-52. Epub 2002 Mar 4.

35.

Dual function of rhoD in vesicular movement and cell motility.

Murphy C, Saffrich R, Olivo-Marin JC, Giner A, Ansorge W, Fotsis T, Zerial M.

Eur J Cell Biol. 2001 Jun;80(6):391-8.

PMID:
11484930
36.

Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages.

Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C.

J Pharmacol Exp Ther. 2001 Jan;296(1):181-7.

PMID:
11123379
37.

The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A.

Breit S, Ashman K, Wilting J, Rössler J, Hatzi E, Fotsis T, Schweigerer L.

Cancer Res. 2000 Aug 15;60(16):4596-601.

38.

MYCN oncogene and angiogenesis: down-regulation of endothelial growth inhibitors in human neuroblastoma cells. Purification, structural, and functional characterization.

Hatzi E, Breit S, Zoephel A, Ashman K, Tontsch U, Ahorn H, Murphy C, Schweigerer L, Fotsis T.

Adv Exp Med Biol. 2000;476:239-48.

PMID:
10949669
39.

N-myc down-regulates activin A.

Breit S, Rössler J, Fotsis T, Schweigerer L.

Biochem Biophys Res Commun. 2000 Aug 2;274(2):405-9.

PMID:
10913351
40.

Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells.

Fotsis T, Breit S, Lutz W, Rössler J, Hatzi E, Schwab M, Schweigerer L.

Eur J Biochem. 1999 Aug;263(3):757-64.

41.

Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis.

Gong H, Zölzer F, von Recklinghausen G, Rössler J, Breit S, Havers W, Fotsis T, Schweigerer L.

Biochem Biophys Res Commun. 1999 Jul 22;261(1):10-4.

PMID:
10405315
42.

Phytoestrogens and inhibition of angiogenesis.

Fotsis T, Pepper MS, Montesano R, Aktas E, Breit S, Schweigerer L, Rasku S, Wähälä K, Adlercreutz H.

Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):649-66. Review.

PMID:
10384818
43.

Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid.

Pappa A, Seferiadis K, Fotsis T, Shevchenko A, Marselos M, Tsolas O, Messinis IE.

Hum Reprod. 1999 Jun;14(6):1449-56.

PMID:
10357957
44.

Comment on altered hydroxylation of estrogen in patients with postmenopausal osteopenia.

Adlercreutz H, Fotsis T.

J Clin Endocrinol Metab. 1998 Nov;83(11):4170-1. No abstract available.

PMID:
9814509
45.

Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.

Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wähälä K, Montesano R, Schweigerer L.

Cancer Res. 1997 Jul 15;57(14):2916-21.

46.

[Inhibition of neovascularization of the eye by dietary factors exemplified by isoflavonoids].

Kruse FE, Joussen AM, Fotsis T, Schweigerer L, Rohrschneider K, Völcker HE.

Ophthalmologe. 1997 Feb;94(2):152-6. German.

PMID:
9156641
47.

Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry.

Wilm M, Shevchenko A, Houthaeve T, Breit S, Schweigerer L, Fotsis T, Mann M.

Nature. 1996 Feb 1;379(6564):466-9.

PMID:
8559255
48.

Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples.

Mazur W, Fotsis T, Wähälä K, Ojala S, Salakka A, Adlercreutz H.

Anal Biochem. 1996 Jan 15;233(2):169-80.

PMID:
8789715
49.

Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate.

Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, Maragoudakis ME.

Br J Pharmacol. 1995 Sep;116(2):1829-34.

50.

Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients.

Lønning PE, Johannessen DC, Lien EA, Ekse D, Fotsis T, Adlercreutz H.

J Steroid Biochem Mol Biol. 1995 May;52(5):491-6. Erratum in: J Steroid Biochem Mol Biol 1996 Jan;57(1-2):149.

PMID:
7748814

Supplemental Content

Loading ...
Support Center